‹ ›
MYP_077462
← PREVIOUS NEXT → BACK
Basic Information
G158-189(derived from RSV attachment glycoprotein)
Antimicrobial
Antiviral
Antiviral ▸ Anti-Pneumovirus ▸ Anti-RSV
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition
Therapeutic / Biomedical activity ▸ Protective bioactivity ▸ Cell protection ▸ Cytoprotection
Standard
32 amino acids
C168H247N45O45S4
Standard
Sequence
KPNNDFHFEVFNFVPCSICSNNPTCWAICKRI
Physicochemical Analysis
3745.29 Da
7.89
0.81
0.49
0.0253
-0.10
0.37
0.07
12.69
57.81
0.1562
5500.00
5750.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1448.20
-13.60
51.0
51.0
114.0
262.0
10.0
36.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0128771 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Disulfide bond(s) reported
Bio-Activity Profile
Antimicrobial Antiviral
Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells
25 μM
IC50
PaperPubMed PMID: 11487583 PMID11487583 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/11487583/
RECORD: Rec_0326209 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
The peptide formed two disulfide bonds.
Bio-Activity Profile
Antiviral Anti-RSV Entry inhibition
Respiratory syncytial virus(RSV) | HEp-2 cells
25 μM
IC50
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min
PaperAntiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein. | Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. | J Biol Chem. 2001 Oct 19;276(42):38988-94. | DOI:10.1074/jbc.M106288200 | PMID:11487583 PMID11487583 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/11487583/
RECORD: Rec_0360352 VERIFIED: YES
Provenance & Taxonomy
Human orthopneumovirus [Virus]
Virus-derived peptide
11250;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Cytoprotective
Respiratory syncytial virus (Cytopathic effect); HEp-2
25 μM
NMR
PaperAntiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein. | Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ. | J Biol Chem. 2001 | PMID:11487583 PMID11487583 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/11487583/
RECORD: Rec_0386871 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Disulfide bond(s) reported
Bio-Activity Profile
Antimicrobial Antiviral
PaperPubMed PMID: 11487583 PMID11487583 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/11487583/
RECORD: Rec_0405603 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 31.2%, E 0.0%, T 21.9%, C 46.9% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/